Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · IEX Real-Time Price · USD
34.59
-0.61 (-1.73%)
At close: Jul 2, 2024, 4:00 PM
34.57
-0.02 (-0.06%)
After-hours: Jul 2, 2024, 7:00 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.03 billion as of July 2, 2024. Its market cap has increased by 28.35% in one year.
Market Cap
2.03B
Enterprise Value
1.71B
1-Year Change
28.35%
Ranking
Category
Stock Price
$34.59
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.03B, an increase of 1,082.96%. That is a compound annual growth rate of 36.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 2.06B | 56.10% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CONMED | 2.14B |
| Patterson Companies | 2.12B |
| CG Oncology | 2.10B |
| Fortrea Holdings | 2.09B |
| Privia Health Group | 2.07B |
| UFP Technologies | 2.02B |
| Astrana Health | 1.98B |
| Vera Therapeutics | 1.98B |